Pfizer: oral antiviral treatment against Covid-19 in trial

Tweet

medicamentThe pharmaceutical company Pfizer has begun the phase 1 trials of an antiviral treatment against Covid-19. Administered orally, the new drug is to be used as soon as the first symptoms of SARS-CoV-2 appear.

The antiviral agent inhibits the reproduction of the virus in the cells according to a process known in anti-HIV and hepatitis C treatments.

Alongside this first treatment, Pfizer is also launching the phase 1 trials of a second treatment administered intravenously. The tests are being conducted on patients hospitalized with Covid-19.

Read also | Covid-19 vaccine: ranking of countries per doses administered

0
Your rating: None
Fri, 26/03/2021 - 09:41
© 2024 Groupe Atlas
Advertising Program          Terms of Service          Copyright          Useful links          Social networks          Credits